Send feedback

PTEN p.Phe341Cys

c.1022T>G · rs1860635056 · VCV847564

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.9953 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
PTEN hamartoma tumor syndrome

Computational evidence

Protein change
AlphaMissense0.9953likely pathogenic
REVEL0.932strongly pathogenic-leaning
SaProtLLR -13.76damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAIΔ0.46donor gain · deltas
Constraint at this position
ConservationphyloP 7.9GERP 2.6, phastCons 1
Regional constrainto/e 0.51unconstrained · MANE · 32 kb · p 4.1e-17 · regional, not allelic
Overall
CADD35.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene
PTEN
Protein
p.Phe341Cys
Coding
c.1022T>G
MANE Select
NM_000314
dbSNP
rs1860635056
Type
single nucleotide variant
Location
chr10:87961114 (GRCh38)
Gene constraint
LOEUF 0.685 · pLI 0.05 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 83.76 · 12 PDB
Residue 341
a UniProt-annotated variant site (in cws1; loss of interaction with nop53; decreased phosphorylation at s-380; decreased stability; loss of phosphatase activity towards ins(1,3,4,5)p4); the c2 tensin-type domain; the 'required for interaction with nop53' region; a UniProt-annotated variant site (in mcephas)
Full PTEN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

PTEN hamartoma tumor syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For PTEN hamartoma tumor syndrome (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-9 / 100 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pten-p-phe341cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown